TNG260Mutation Finder

TNG260-101 is a phase 1/2 clinical trial for patients with locally advanced or metastatic cancer solid tumors with an STK11 loss-of-function mutation. Via this search tool, you can determine whether a patient’s tumor has an STK11 mutation that may be eligible for the trial.